Dow Up 0.20% Nasdaq Down 0.24%

Agios Pharmaceuticals, Inc. (AGIO)

-NasdaqGS
39.75 Down 0.67(1.66%) 10:12AM EDT - Nasdaq Real Time Price
Prev Close:40.42
Open:40.20
Bid:39.76 x 200
Ask:39.83 x 100
1y Target Est:59.25
Beta:1.979
Next Earnings Date:N/A
Day's Range:39.69 - 40.24
52wk Range:15.77 - 50.37
Volume:48,005
Avg Vol (3m):337,022
Market Cap:1.37B
P/E (ttm):N/A
EPS (ttm):-2.09
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for AGIO

Comparison

Symbol% ChgMkt Cap
AGIODown 1.66%1.37B
ALXNUp 0.31%33.48B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):46.68
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.94
Quarterly EPS Est (Sep-14) :-0.53
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Agios Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics in the field of cancer metabolism and inborn errors of metabolism (IEMs) in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback